Author

Adam Kopon

PHASE III RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF ADD-ON FIXED-DOSE ANTI-MYCOBACTERIAL THERAPY (RHB-104) IN MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE (MAP US)

David Y. Graham, Robert Hardi, Thomas Welton, Richard Krause, Scott Levenson, Harry Sarles, Aasim Sheikh, Michael S Epstein, George Duvall, Curtis Freedland, Zbigniew Hebzda, Tomasz Arlukowicz, Adam Kopon, Grzyna Rydzewska, Natasa Zdravkovic, Peter Svorcan, Eran Zittan, Predrag Dugalic, Eran Israeli, Patricia Anderson,

Item 1 - 1 / 1
1